LGD Holdings

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The company's business model is based on developing and licensing a diversified portfolio of biotech assets, which provides a sustainable and high-margin revenue stream through royalties, milestones, and license fees. Ligand's core technologies include the OmniAb antibody discovery platform and the Captisol drug formulation technology, which is used in several FDA-approved drugs. By partnering with major pharmaceutical companies, Ligand maintains a broad pipeline of programs across various therapeutic areas, including oncology, immunology, and metabolic diseases.